Search clinical trials for: Azithromycin (T1225)

Total 598 results

Laboratoires Thea

Completed

Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy Volunteers

Eye Infections, Bacterial
Laboratoires Thea

Completed

Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy Volunteers

Eye Infections, Bacterial

France
Laboratoires Thea

Completed

Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis

Conjunctivitis, Bacterial
Laboratoires Thea

Completed

Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy Volunteers

Eye Infections, Bacterial
Laboratoires Thea
Keyrus Biopharma; VEEDA

Completed

Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis

Blepharitis

France
Institute for Research and Development of Medicinal...

Unknown

Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients (PHYTCOVID-19)

Covid19

Guinea
University of California, San Francisco
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger

Chlamydia Trachomatis | Trachoma

United States, Niger
University Hospital, Montpellier
Rheonova

Recruiting

Chronic Airway Disease, Mucus Rheology and Exacerbations (COPD-CARhE)

Chronic Obstructive Pulmonary Disease

France
Institute for Research and Development of Medicinal...

Unknown

Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients (CANCOVID-19)

Covid19

Guinea
Shahid Sadoughi University of Medical Sciences...

Completed

Aizthromycin or Clarithromycin in H-pylori Eradication Regimen (H-pylori)

Dyspepsia | Peptic Ulcer | H-pylori

Iran, Islamic Republic of
Johns Hopkins Bloomberg School of Public Health
Bill and Melinda Gates Foundation; International Centre for Diarrhoeal Disease...

Completed

Protein Plus: Improving Infant Growth Through Diet and Enteric Health (JiVitA-6)

Stunting | Campylobacter Infections | Malnutrition; Protein | Enteric Pathogens

Bangladesh
Assistance Publique Hopitaux De Marseille

Completed

Medico-economic Impact of Screening Atopobium Vaginae and Gardnerella Vaginalis in Molecular Biology by "Point-of-care" During Pregnancy (AuTop)

Low Risk of Preterm Delivery

France
Universidad de Antioquia
Colgate Palmolive

Completed

Study on Periodontal Treatment in Diabetic Patients

Diabetes | Periodontitis | Gingivitis

Colombia
Laboratoires Thea

Completed

Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children.

Purulent Bacterial Conjunctivitis

France
Apsen Farmaceutica S.A.
Federal University of São Paulo

Withdrawn

Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)

Coronavirus Infections | SARS-CoV 2 | Pulmonary Disease | SARS (Severe Acute Respiratory Syndrome)

Brazil
Guilan University of Medical Sciences

Completed

To Compare Ofloxacin With Azitromycin for Pelvic Inflammatory Disease (PID) Treatment (CTO)

Pelvic Inflammatory Disease

Iran, Islamic Republic of
Washington University School of Medicine

Completed

Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis-II (APW-RSV-II)

Respiratory Syncytial Virus, Bronchiolitis

United States
Pfizer

Completed

A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin Sustained Release Versus 3-Day Azithromycin for the Treatment of Strep Throat in Adolescents and Adults

Tonsillitis | Pharyngitis

Belgium, India, Germany, United States, France, United Kingdom, Netherlands, Finland, Italy, Norway
Sheba Medical Center

Unknown

Typhoid Fever: Combined vs. Single Antibiotic Therapy

Typhoid Fever

Nepal
Pfizer

Completed

Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan)

Bacterial Infections
Thomas Jefferson University
Christiana Care Health Services

Completed

Azithromycin Dose and PPROM Treatment: a Pilot Randomized Controlled Trial (ADAPT)

Preterm Premature Rupture of Membrane

United States
GlaxoSmithKline

Completed

A Single and Repeat Dose PK/PD Study to Characterise Biomarker Response in Healthy Subjects Treated With Azithromycin

Autoimmune Diseases

United Kingdom
Emory University
The Carter Center

Suspended

Trachoma Elimination Study by Focused Antibiotic (TESFA)

Trachoma

Ethiopia
University of Alabama at Birmingham
Merck Sharp & Dohme LLC

Completed

Antibiotic Prophlaxis for High-risk Laboring Women in Low Income Countries

Postpartum Sepsis | Postpartum Endometritis | Postpartum Fever

Cameroon
Pfizer

Completed

A Randomized, Open Label, Clinical Trial of the Pharmacokinetics of Azithromycin Following a Single Dose of Azithromycin Sustained Release (2 Gram) or Commercial Azithromycin Tablet (500 mg) to Cancer Patients That Require Lung Surgery

Pharmacokinetics

Italy
University of Alabama at Birmingham

Completed

Prospective Pilot Clinical Trial of Azithromycin Treatment In Respiratory Syncytial Virus (RSV)- Induced Respiratory Failure In Children

Respiratory Syncytial Virus

United States
KU Leuven
Fund for Scientific Research, Flanders, Belgium

Completed

Study of Azithromycin for Lymphocytic Bronchiolitis/Bronchitis After Lung Transplantation (AZI002)

Lymphocytic Bronchi(Oli)Tis Post-lung Transplantation

Belgium
Seattle Children's Hospital
National Heart, Lung, and Blood Institute (NHLBI); Cystic Fibrosis Foundation; CF Therapeutics Development Network Coordinating Center

Completed

Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With Cystic Fibrosis (CF) (TEACH)

Cystic Fibrosis

United States
Emory University

Completed

Enhancing the A in SAFE for Trachoma

Trachoma

South Sudan
Lihir Medical Centre
World Health Organization; Harvard School of Public Health (HSPH); Barcelona... and other collaborators

Completed

Evaluation of an Intensive 3-round MDA Strategy Towards Yaws Eradication

Yaws

Papua New Guinea
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Azithromycin and Coronary Events Study (ACES)

Myocardial Infarction | Heart Diseases | Cardiovascular Diseases | Coronary Disease
Johns Hopkins University

Terminated

Macrolides to Prevent Exacerbations of Asthma and Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease | Asthma

United States
Sandoz

Completed

To Demonstrate the Relative Bioavailability of Azithromycin 600 mg Tablets Under Fed Conditions

Infection
Samsung Medical Center

Completed

Microorganism in Overactive Bladder Patients

Overactive Bladder

Korea, Republic of
Wisconsin Research Network

Completed

ASTHMA (AntibioticS To Help Manage Asthma) Pilot Study

Asthma
Odense University Hospital

Unknown

Prophylactic Antibiotic Treatment of Patients With Chronic Obstructive Lung Disease (COLD)

Pulmonary Disease, Chronic Obstructive

Denmark
Pfizer

Completed

Pharmacokinetics Of Azithromycin Immediate Release And Extended Release Formulation In Kids With Acute Otitis Media

Acute Otitis Media

Costa Rica
Pfizer

Terminated

Efficacy And Safety Of Azithromycin SR Compared With Minocycline In Acne

Acne Vulgaris

Italy
Tel-Aviv Sourasky Medical Center

Unknown

The Efficacy of Prednisone and Azithromycin in the Treatment of Patients With Cat Scratch Disease

Cat-scratch Disease | Bartonella Infections

Israel
Beni-Suef University

Not yet recruiting

Effect Of Azithromycin in Women at Risk of Preterm Labour

Preterm Labor

Egypt
Tel-Aviv Sourasky Medical Center
Tel Aviv University

Unknown

Azithromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis (FAP)

Familial Adenomatous Polyposis

Israel
Universitaire Ziekenhuizen KU Leuven

Unknown

Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 4. (BioSput-Air)

Asthmatic Patients

Belgium
Bangabandhu Sheikh Mujib Medical University, Dhaka...

Recruiting

Influence of Ethnicity and ABCB1 Gene Polymorphism on the Pharmacokinetics of Azithromycin in Healthy Bangladeshi Volunteers

Comparative Bioavailability Study

Bangladesh
University of Oxford
Pfizer

Completed

A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2) (ATOMIC2)

COVID-19

United Kingdom
University Hospital Inselspital, Berne
University of Bern

Completed

Azithromycin in Idiopathic Pulmonary Fibrosis

Cough | Idiopathic Pulmonary Fibrosis

Switzerland
Pfizer

Completed

A Trial Of Azithromycin SR For The Treatment Of Mild To Moderate Community Acquired Pneumonia In Japanese Adults

Pneumonia, Community-Acquired

Japan
Pfizer

Completed

A Trial Of Azithromycin SR For The Treatment Of Laryngopharyngitis or Tonsillitis or Acute Bacterial Rhinosinusitis

Upper Respiratory Tract Infection

Japan
Indonesia University

Completed

The Efect of Azithromicyn on Bronchopulmonary Displasia in Extremely Preterm and Very Preterm Infant

Necrotizing Enterocolitis | Intraventricular Hemorrhage | Bronchopulmonary Dysplasia

Indonesia
Pfizer

Completed

A Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases

Acute Bronchitis

Japan
University of Milan
Pfizer

Terminated

Azithromycin Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD) and Tracheostomy

Tracheostomy | COPD

Italy

3

Subscribe